Abstract
Properly treated, unstable angina and non-Q wave myocardial infarction have low hospital mortality, but if untreated, mortality is high. Symptoms and labs usually suffice for diagnosis. Abnormal physical findings are rarely helpful and often absent. Careful surveillance and management, including invasive management in selected cases, substantially reduce long-term risks.
Similar content being viewed by others
References
Wehrmacher WH, Bellows R. Unstable angina. Compr Ther 2004; 30(1):6–9.
Methot J, Hammelin B, Bogaty P, et al. Differences in the clinical presentation of acute coronary syndrome between premenopausal and postmenopausal women. Circulation 2002;106(Suppl II):540.
Skolnick A, Peterson E, Alexander A, et al. Treatment and outcomes of acute coronary syndromes among 5,577 Patients <90 years. J Am Coll Cardiol 2006;47 (Suppl A):253A.
Iliescu C, Giesler G, Hemstreet A, et al. Natural catastrophic events are associated with increased incidence and severity of acute coronary syndromes J Am Coll Cardiol.
Armstrong E, Morrow D, Sabine M. Inflammatory biomarkers in acute coronary syndrome. Circulation 2006;113.
Aquiar C, Ferreira J. Compliance with contemporary guidelines for non-ST-evaluation acute coronary syndromes. J Am Coll Cardiol 2006;47(Suppl A):257A.
de Winter R, Windhausen F, Cornel J, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Eng J Med 2005;353:1095–1104.
Kahlid M, Adamaiyle J, Papadakos S, et al. A routine intervention strategy in patients with non-ST segment elevation acute coronary syndromes is not superior to a selective intervention strategy. J Am Coll Cardiol 2006;47(Suppl A):257A.
Popp A, Nadalar M, Vaikus P. Early invasive versus conservative management in non ST elevation acute coronary syndromes: a met-analysis. J Am Coll Cardiol 2006;47(Suppl A):205A.
Author information
Authors and Affiliations
Corresponding author
Additional information
The author has stated that he has no significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The author also does not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.
About this article
Cite this article
Wehrmacher, W.H. Unstable angina treatment 2006 Update . Compr Ther 32, 144–146 (2006). https://doi.org/10.1007/s12019-006-0003-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12019-006-0003-8